We describe a method for comparing plasma samples from healthy subjects and from chronic uremic patients before and after dialysis. It was used to determine the nature of those metabohtes that appear to characterize the uremic state. Preliminary fractionation of the metabolites by gel chromatography was followed by removal of the aqueous effluent by lyophilization and preparation of volatile trimethylsilyl derivatives, which were then examined by gas-liquid chromatography. Gas-liquid chromatography/mass spectrometry was used to characterize and identify individual metabolites. Gas-liquid chromatographic patterns of plasma from healthy and uremic subjects differ markedly, more so than do individual plasma samples within the same class of subjects. Concentrations of many metabolites are increased in uremia, but after dialysis of the patient's blood, the concentrations become about the same as those in healthy plasma. We have observed some 150-200 metabolites in each category of plasma. We have tentatively identified about a tenth of the compounds that appear to be specific to or increased in uremia, including lactic acid, glycerol, erythritol, erythronic acid, 2-deoxy erythro pentonic acid, arabinitol, arabinonic acid, inositol, and lactose. Some of these are present in concentrations >20 mg/liter and have not been previously reported as occurring in the uremic state. 
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Experimental Methods

Blood Samples
Protein was satisfactorily resolved from the bulk of low-molecular-weight species by passage through the three columns, the effluent collected to a Kd of 3 and combined into 10 fractions, which varied in volume from 16 ml for the first to 400 ml for the tenth, as the peak width of the eluted compounds increased with elution volume. Usually no metabolic species were observed in the last two or three fractions, but these were routinely checked. Proteins were present in fractions two and three, and after fil- were obtained at 70 eV, trap current 500 tA, and accelerating voltage 8 kV, by scanning from the top of the GLC peak, as indicated by the total ion-current monitor coupled to a strip-chart recorder, and recorded on ultraviolet-sensitive paper at three sensitivities over a range of 1000 to 28 atomic mass units.
We examined several different methods of matching spectra.
These included, first, the extraction of the eight most intense ions in order of decreasing intensity and, second, extraction of the eight most intense ions in any order. Successful matching by both these methods was limited by variations in spectra caused by continuously varying sample pressure in the ion source while a GLC peak was being scanned. This was overcome to a certain extent by scanning from the peak maximum down the trailing side of the peak, but this assumed perfect GLC resolution from other components.
The third method involved comparing the two or three most intense peaks from blocks of 14 atomic mass units, and it is that used by High-resolution data for individual ions in each spectrum are now being obtained. This is a slow process, as only one ion can be measured on each GLC peak, assuming 1-mm peak separation, and the number of times this can be done is often limited by the amount of sample available. Measurements are confidently within ± 10 ppm and the computer printout of elemental formulas is programmed to include all compounds containing C, H, N, 0, and Si, with unlimited C and H, but zero or up to a maximum of 6, 8, and 10 N, 0, and Si atoms, respectively. Elemental formulas matching the measured mass exactly are 
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----- Fig. 2 . Gas/liquid chromatograms on 21/2% OV-1 of fraction 4 after gel chromatography of plasma from: 2a, uremic male (patient 1), before starting the hemodialysis program; 2b, uremic female (patient 2), six weeks before starting the hemodialysis program; 2c, uremic female (patient 2). immediately before the first hemodialysis treatment; 2d, uremic female (patient 2), at end of the first hemodlalysis treatment; 2e, healthy female Figure 2 shows typical low-sensitivity GLC traces of fraction four of plasma from uremic subjects, before and after dialysis, and from a healthy subject.
The gas chromatograms of plasma from different uremic patients before they commenced the hemodialysis program showed only minor differences (examples are shown in Figures 2a, 2b, and 2c) ; i.e., we obtained gas chromatograms typical of the uremic state. The gas chromatograms from healthy subjects were also very similar to each other (a representative one is shown in Figure  2e ) but they differed markedly from those of pre-dialysis plasma from a uremic subject.
The heights of most of the peaks obtained from the uremic subject's plasma were much higher than those in the healthy subject, indeed, about 100 compounds in uremic plasma were at concentrations exceeding 5 mg/liter, but in contrast only about a dozen of these compounds appeared in control plasma above this concentration.
One or two peaks obtained on GLC of plasma from healthy persons were sometimes higher than the equivalent peaks in samples from uremic subjects. 
